It has been suggested that PALB2 contributes to carcinogenesis through haploinsufficiency and/or a dominant negative effect given the paucity of LOH observed in the majority of breast cancer cases from PALB2 carriers[3,4,6,10], with the exception of one study where a high frequency of LOH was seen [2]. The gene discussed is PALB2; the disease is breast cancer.